A really positive piece of news via the BBC today, about stem cell therapy trials for heart attack victims in a London hospital.
Please read the whole article here, but the bit that caught my eye was this statement, almost at the end- on how its being paid for and why…
John Martin, professor of cardiovascular medicine at University College London and adjunct professor of medicine at Yale, said: “This trial does not have the backing of the pharmaceutical industry as there is no money in it for them. You can’t patent a patient’s own cells.
“So not only could this treatment save lives it could also save the NHS money.”